Intravenous products: MedGadget.com report “The FDA issued approval for Antares Pharma’s (Ewing, New Jersey) needle-freeÂ injection device for use with Tev-Tropin brand human growth hormone (hGH) from Teva out of Petach Tikva, Israel. The device will be marketed under the name Tev-Tropin Tjet Injector system”.
Teva will market the Antares needle-free device as the Tev-Tropin Tjet Injector system.
“We are pleased to add this new technology to our growing portfolio through our successful partnership with Antares, and to offer patients a less invasiveÂ delivery system,” stated Larry Downey, head of Teva`s North America BrandÂ Pharmaceuticals division. “This significant achievement demonstrates our abilityÂ to leverage our leadership in the pharmaceutical industry, and our ongoingÂ commitment to utilize our global strengths in innovative activities.”